Eptifibatide-induced profound thrombocytopaenia: a rare complication.
Publication/Presentation Date
6-14-2021
Abstract
Drug-induced immune thrombocytopaenia (DITP) is a type of thrombocytopaenia caused by medications. It is one of the common causes of unexplained thrombocytopaenia. It is caused by the formation of autoantibodies against a particular drug and is commonly observed with medications like heparin and beta-lactam antibiotics. One of the rare causes of DITP is eptifibatide, a widely used antiplatelet agent for pretreatment in cardiac catheterisation. These patients can be asymptomatic or develop complications like skin bruising, epistaxis and even intracranial haemorrhage. We present a case of a 64-year-old man who developed eptifibatide-induced profound thrombocytopaenia leading to extensive skin bruising. He was treated with platelet transfusions followed by prompt improvement in platelet count.
Volume
14
Issue
6
ISSN
1757-790X
Published In/Presented At
Mahajan, P., Ayub, F., Azimi, R., & Adoni, N. (2021). Eptifibatide-induced profound thrombocytopaenia: a rare complication. BMJ case reports, 14(6), e241594. https://doi.org/10.1136/bcr-2021-241594
Disciplines
Medicine and Health Sciences
PubMedID
34127501
Department(s)
Department of Medicine, Cardiology Division, Fellows and Residents
Document Type
Article